<p>, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) 今天宣布，公司管理层成员将于 2026 年 5 月 19 日星期二在德克萨斯州奥斯汀参加巴克莱第 30 届年度杠杆融资会议的炉边谈话。活动的实时音频网络广播将在 Bausch Health 网站的投资者关系部分提供。</p>
<p><strong>详情</strong></p>
<p>日期：2026 年 5 月 19 日星期二</p>
<p>时间：美国东部时间上午 10:25</p>
<p>网络广播：http://ir.bauschhealth.com/events-and-presentations</p>
<p>活动结束后，投资者关系网站将提供活动的重播。</p>
<p><strong>关于 Bausch Health</strong> Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) 是一家全球多元化的制药公司，通过我们不懈的努力提供更好的医疗保健结果，丰富人们的生活。我们开发、生产和销售一系列产品，主要涉及胃肠病学、肝病学、神经科学、皮肤病学、牙科、美容、国际制药和眼健康领域，通过我们对 Bausch + Lomb Corporation 的控股权益实现。我们的目标是成为一家全球一体化的医疗保健公司，受到患者、医疗保健专业人士、员工和投资者的信任和重视。有关 Bausch Health 的更多信息，请访问 www.bauschhealth.com 并在 LinkedIn 上与我们联系。</p>
<p><strong>前瞻性声明</strong> 本新闻稿可能包含适用证券法意义上的前瞻性声明，包括 1995 年美国私人证券诉讼改革法案的安全港条款。前瞻性声明通常可以通过使用 “将”、“预期”、“希望”、“期望”、“打算”、“计划”、“应该”、“可能”、“会”、“相信”、“受限于” 和变体或类似表达来识别。这些声明既不是历史事实，也不是未来表现的保证，而是基于管理层当前的期望和信念，并且受到某些风险和不确定性的影响，这可能导致实际结果与前瞻性声明中描述的结果有实质性差异。实际结果还受到与 Bausch Health 整体业务更广泛相关的其他风险和不确定性的影响，这些因素在 Bausch Health 最近的年度和季度报告中有更详细的描述，并不时在 Bausch Health 向美国证券交易委员会和加拿大证券管理局的其他文件中详细说明，这些因素在此通过引用纳入。读者被提醒不要对这些前瞻性声明过度依赖。这些前瞻性声明仅在此日期有效。公司没有义务更新任何这些前瞻性声明，以反映本新闻稿日期后的事件、信息或情况，或反映实际结果，除非法律要求。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>投资者联系：</strong></td>
<td><strong>媒体联系：</strong></td>
</tr>
<tr>
<td>Garen Sarafian</td>
<td>Katie Savastano</td>
</tr>
<tr>
<td>ir@bauschhealth.com</td>
<td>corporate.communications@bauschhealth.com</td>
</tr>
<tr>
<td>(877) 281-6642 (免费电话)</td>
<td>(908) 569-3692</td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
<tr>
<td>BHC-FINANCIAL</td>
<td></td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2850608/Bausch_Health_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="400" height="163" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2850608/Bausch_Health_Logo.jpg"/></p>
<p>来源：Bausch Health Companies Inc.</p>

<p>Bausch Health Companies Inc.（纽约证券交易所代码：BHC）将于 2026 年 5 月 19 日上午 10:25（美国东部时间）参加巴克莱第 30 届年度杠杆融资会议的炉边谈话。其投资者关系网站将提供直播音频网络广播，之后可访问重播。Bausch Health 是一家全球制药公司，专注于改善各个领域的医疗保健结果。声明中包含前瞻性陈述，提醒不要过度依赖这些陈述</p>

<p>, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that members of company management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) 今天宣布，公司管理层成员将于 2026 年 5 月 19 日星期二在德克萨斯州奥斯汀参加巴克莱第 30 届年度杠杆融资会议的炉边谈话。活动的实时音频网络广播将在 Bausch Health 网站的投资者关系部分提供。</p>
</div><p><strong>Details</strong></p>
<div class="lb-trans"><p><strong>详情</strong></p>
</div><p>Date: Tuesday, May 19, 2026</p>
<div class="lb-trans"><p>日期：2026 年 5 月 19 日星期二</p>
</div><p>Time: 10:25 a.m. U.S. ET</p>
<div class="lb-trans"><p>时间：美国东部时间上午 10:25</p>
</div><p>Webcast: http://ir.bauschhealth.com/events-and-presentations</p>
<div class="lb-trans"><p>网络广播：http://ir.bauschhealth.com/events-and-presentations</p>
</div><p>A replay of the event will be available on the investor relations website following the event.</p>
<div class="lb-trans"><p>活动结束后，投资者关系网站将提供活动的重播。</p>
</div><p><strong>About Bausch Health</strong> Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.</p>
<div class="lb-trans"><p><strong>关于 Bausch Health</strong> Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) 是一家全球多元化的制药公司，通过我们不懈的努力提供更好的医疗保健结果，丰富人们的生活。我们开发、生产和销售一系列产品，主要涉及胃肠病学、肝病学、神经科学、皮肤病学、牙科、美容、国际制药和眼健康领域，通过我们对 Bausch + Lomb Corporation 的控股权益实现。我们的目标是成为一家全球一体化的医疗保健公司，受到患者、医疗保健专业人士、员工和投资者的信任和重视。有关 Bausch Health 的更多信息，请访问 www.bauschhealth.com 并在 LinkedIn 上与我们联系。</p>
</div><p><strong>Forward-looking Statements</strong> This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words &#34;will,&#34; &#34;anticipates,&#34; &#34;hopes,&#34; &#34;expects,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;should,&#34; &#34;could,&#34; &#34;would,&#34; &#34;may,&#34; &#34;believes,&#34; &#34;subject to&#34; and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.</p>
<div class="lb-trans"><p><strong>前瞻性声明</strong> 本新闻稿可能包含适用证券法意义上的前瞻性声明，包括 1995 年美国私人证券诉讼改革法案的安全港条款。前瞻性声明通常可以通过使用 “将”、“预期”、“希望”、“期望”、“打算”、“计划”、“应该”、“可能”、“会”、“相信”、“受限于” 和变体或类似表达来识别。这些声明既不是历史事实，也不是未来表现的保证，而是基于管理层当前的期望和信念，并且受到某些风险和不确定性的影响，这可能导致实际结果与前瞻性声明中描述的结果有实质性差异。实际结果还受到与 Bausch Health 整体业务更广泛相关的其他风险和不确定性的影响，这些因素在 Bausch Health 最近的年度和季度报告中有更详细的描述，并不时在 Bausch Health 向美国证券交易委员会和加拿大证券管理局的其他文件中详细说明，这些因素在此通过引用纳入。读者被提醒不要对这些前瞻性声明过度依赖。这些前瞻性声明仅在此日期有效。公司没有义务更新任何这些前瞻性声明，以反映本新闻稿日期后的事件、信息或情况，或反映实际结果，除非法律要求。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Investor Contact:</strong></td>
<td><strong>Media Contact:</strong></td>
</tr>
<tr>
<td>Garen Sarafian</td>
<td>Katie Savastano</td>
</tr>
<tr>
<td>ir@bauschhealth.com</td>
<td>corporate.communications@bauschhealth.com</td>
</tr>
<tr>
<td>(877) 281-6642 (toll free)</td>
<td>(908) 569-3692</td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
<tr>
<td>BHC-FINANCIAL</td>
<td></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>投资者联系：</strong></td>
<td><strong>媒体联系：</strong></td>
</tr>
<tr>
<td>Garen Sarafian</td>
<td>Katie Savastano</td>
</tr>
<tr>
<td>ir@bauschhealth.com</td>
<td>corporate.communications@bauschhealth.com</td>
</tr>
<tr>
<td>(877) 281-6642 (免费电话)</td>
<td>(908) 569-3692</td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
<tr>
<td>BHC-FINANCIAL</td>
<td></td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2850608/Bausch_Health_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/2850608/Bausch_Health_Logo.jpg"/></p>
<p>SOURCE Bausch Health Companies Inc.</p>
<div class="lb-trans"><p>来源：Bausch Health Companies Inc.</p>
</div>

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference | BHC Stock News

Bausch Health 将参与巴克莱第 30 届年度杠杆融资会议 | BHC 股票新闻